Focus on microalbuminuria to improve cardiac and renal protection.

  title={Focus on microalbuminuria to improve cardiac and renal protection.},
  author={Paul E. de Jong and Ronald T. Gansevoort},
  journal={Nephron. Clinical practice},
  volume={111 3},
  pages={c204-10; discussion c211}
With the recent attention to diagnose earlier stages of chronic kidney diseases (CKD), most attention focuses on screening for an impaired estimated glomerular filtration rate (eGFR), i.e. CKD stages 3-5. Less attention is given to the impact of the urinary leakage of albumin. Its presence is not taken into account in the definition of stages 3-5, but only required to diagnose stages 1 and 2. As in stages 1 and 2 CKD, eGFR is not or only modestly impaired, these stages are generally considered… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-10 of 10 extracted citations


Publications referenced by this paper.
Showing 1-10 of 49 references

Comparison of screening approaches for chronic kidney disease

  • M Van der Velde, PE de Jong, RT Gansevoort
  • J Am Soc Nephrol
  • 2008

First morning voids or spot urine samples for determination of microalbuminuria

  • EC Witte, HJ Lambers Heerspink, SJL Bakker, PE de Jong, D de Zeeuw, RT Gansevoort
  • J Am
  • 2008

Winnearls C: An epidemic of chronic kidney disease: fact or fiction

  • RJ Glassock
  • Nephron Dial Transplant
  • 2008

diovascular and renal outcome in subjects with K / DOQI stages 1 – 3 chronic kidney disease ; the importance of urinary albumin excretion

  • AH Brantsma, Bakker SJL, HL Hillege, D deZeeuw, PE deJong, RT Gansevoort
  • Nephrol Dial Transplant
  • 2008

Similar Papers

Loading similar papers…